{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:44:32Z","timestamp":1768520672226,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gofs.2018.10.017","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T13:13:44Z","timestamp":1541164424000},"page":"1043-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Choix et dur\u00e9e de l\u2019antibioprophylaxie en cas de rupture pr\u00e9matur\u00e9e des membranes avant terme. RPC rupture pr\u00e9matur\u00e9e des membranes avant terme CNGOF"],"prefix":"10.1016","volume":"46","author":[{"given":"M.","family":"Doret Dion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cazanave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Charlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.10.017_bib0005","series-title":"Prise en charge du nouveau n\u00e9 \u00e0 risque d\u2019infection n\u00e9onatale bact\u00e9rienne pr\u00e9coce (>34SA)","author":"Soci\u00e9t\u00e9 fran\u00e7aise de n\u00e9onatologie","year":"2017"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.017_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1471-0528.2010.02766.x","article-title":"Mycoplasmas in pregnancy","volume":"118","author":"Taylor-Robinson","year":"2011","journal-title":"Int J Obstet Gynaecol"},{"issue":"46","key":"10.1016\/j.gofs.2018.10.017_bib0015","article-title":"Infection intra-ut\u00e9rine\u00a0: diagnostic et traitement. RPC rupture pr\u00e9matur\u00e9e des membranes avant terme","author":"Beucher","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0020","article-title":"ACOG Practice Bulletin No. 188: prelabor rupture of membranes","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.017_bib0025","series-title":"Preterm Labour and Birth","author":"NICE","year":"2015"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.017_bib0030","article-title":"No. 233-Antibiotic therapy in preterm premature rupture of the membranes","volume":"39","author":"Yudin","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.gofs.2018.10.017_bib0035","first-page":"182","article-title":"Impact of latency duration on the prognosis of preterm infants after preterm premature rupture of membranes at 24\u00a0to 32\u00a0weeks\u2019 gestation: a national population-based cohort study","author":"Lorthe","year":"2017","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CMR.00031-13","article-title":"Early-onset neonatal sepsis","volume":"27","author":"Simonsen","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.017_bib0045","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/jp.2011.40","article-title":"Early-onset neonatal sepsis: rate and organism pattern between 2003\u00a0and 2008","volume":"31","author":"Sgro","year":"2011","journal-title":"J Perinatol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.017_bib0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1542\/peds.2010-2217","article-title":"Early onset neonatal sepsis: the burden of group B Streptococcal and E.\u00a0coli disease continues","volume":"127","author":"Stoll","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.017_bib0055","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2012-3979","article-title":"Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants","volume":"132","author":"Mitha","year":"2013","journal-title":"Pediatrics"},{"issue":"46","key":"10.1016\/j.gofs.2018.10.017_bib0060","article-title":"\u00c9pid\u00e9miologie, facteurs de risque et pronostic de l\u2019enfant. RPC Rupture pr\u00e9matur\u00e9e des membranes avant terme","author":"Lorthe","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.gofs.2018.10.017_bib0065","unstructured":"CNR-Strep, Centre national de r\u00e9f\u00e9rence des streptocoques - Rapport d\u2019activit\u00e9 2016. https:\/\/cnr-strep.fr\/CNR-STREP\/rapport\/rapport_CNR-strep_2016.pdf."},{"issue":"5","key":"10.1016\/j.gofs.2018.10.017_bib0070","doi-asserted-by":"crossref","first-page":"F474","DOI":"10.1136\/archdischild-2017-313238","article-title":"Antimicrobial resistance in UK neonatal units: neonIN infection surveillance network","volume":"103","author":"Cailes","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.gofs.2018.10.017_bib0075","unstructured":"SPILF, Recommandations de bonne pratique\u00a0: infections urinaires au cours de la grossesse. http:\/\/www.infectiologie.com\/UserFiles\/File\/spilf\/recos\/infections-urianires-grossesse-spilf-2015.pdf."},{"issue":"5","key":"10.1016\/j.gofs.2018.10.017_bib0080","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/cid\/civ367","article-title":"Escherichia coli meningitis features in 325\u00a0children from 2001\u00a0to 2013\u00a0in France","volume":"61","author":"Basmaci","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.017_bib0085","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JCM.03255-12","article-title":"Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E.\u00a0coli ST131","volume":"51","author":"Birgy","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.017_bib0090","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/jac\/dkq153","article-title":"CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission","volume":"65","author":"Dubois","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.017_bib0095","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/AAC.35.7.1267","article-title":"Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification","volume":"35","author":"Leclercq","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/MB:28:1:47","article-title":"Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics","volume":"28","author":"Roberts","year":"2004","journal-title":"Mol Biotechnol"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.017_bib0105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.1997.03550120049032","article-title":"Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","volume":"278","author":"Mercer","year":"1997","journal-title":"JAMA"},{"issue":"9261","key":"10.1016\/j.gofs.2018.10.017_bib0110","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(00)04233-1","article-title":"Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial","volume":"357","author":"Kenyon","year":"2001","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.diagmicrobio.2015.01.014","article-title":"Screening for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium should it be integrated into routine pregnancy care in French young pregnant women?","volume":"82","author":"Peuchant","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.017_bib0120","article-title":"Antibiotics for preterm rupture of membranes","author":"Kenyon","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.017_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.07.008","article-title":"Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis","volume":"199","author":"Hutzal","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.017_bib0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2393-8-14","article-title":"MRC ORACLE Children Study. Long term outcomes following prescription of antibiotics to pregnant women with either spontaneous preterm labour or preterm rupture of the membranes","volume":"8","author":"Kenyon","year":"2008","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.017_bib0135","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2015-310144","article-title":"The ORACLE Children Study: educational outcomes at 11years of age following antenatal prescription of erythromycin or co-amoxiclav","volume":"102","author":"Marlow","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9261","key":"10.1016\/j.gofs.2018.10.017_bib0140","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(00)04234-3","article-title":"Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative roup","volume":"357","author":"Kenyon","year":"2001","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.gofs.2018.10.017_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.12.022","article-title":"A retrospective review of ampicillinsulbactam and amoxicillin+clavulanate vs cefazolin\/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes","author":"Ehsanipoor","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.017_bib0150","doi-asserted-by":"crossref","first-page":"F187","DOI":"10.1136\/adc.2002.022731","article-title":"Neonatal necrotising enterocolitis and perinatal exposure to coamoxyclav","volume":"89","author":"Al-Sabbagh","year":"2004","journal-title":"Arch Child Fetal Neonatal Ed"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.017_bib0155","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-3016.2010.01132.x","article-title":"Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics","volume":"24","author":"Kuhn","year":"2010","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.017_bib0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jgyn.2007.12.002","article-title":"Prevention of early-onset group B streptococcus neonatal diseases. The 2005\u00a0experience of the Lille University Health Center","volume":"37","author":"Thibaudon Baveux","year":"2008","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.017_bib0165","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0002-9378(99)70307-8","article-title":"Antibiotic use in pregnancy and drug-resistant infant sepsis","volume":"181","author":"Mercer","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.017_bib0170","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-1573","article-title":"No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18\u00a0years","volume":"125","author":"Puopolo et","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.017_bib0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa012657","article-title":"Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants","volume":"347","author":"Stoll","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12884-017-1432-3","article-title":"Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review","volume":"17","author":"Seedat","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.gofs.2018.10.017_bib0185","first-page":"123","article-title":"Antibiotics and the intestinal microbiome: individual responses, resilience of the ecosystem, and the susceptibility to infections","volume":"398","author":"Thiemann","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.017_bib0190","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/JCM.43.11.5588-5592.2005","article-title":"Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge","volume":"43","author":"De La Cocheti\u00e8re","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.017_bib0195","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01693-15","article-title":"Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces","volume":"6","author":"Zaura","year":"2015","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.017_bib0200","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/cid\/civ333","article-title":"High rate of acquisition but short duration of carriage of multidrug-resistant enterobacteriaceae after travel to the tropics","volume":"61","author":"Rupp\u00e9","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.017_bib0205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/cid\/cir522","article-title":"Massive increase, spread, and exchange of extended spectrum \u03b2-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger","volume":"53","author":"Woerther","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000443360","article-title":"Effects of antibiotics on gut microbiota","volume":"34","author":"Lange","year":"2016","journal-title":"Dig Dis Basel Switz"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.017_bib0215","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.00848-13","article-title":"Characterization of fecal extended-spectrum-\u03b2-lactamase-producing Escherichia coli in a remote community during a long time period","volume":"57","author":"Woerther","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.017_bib0220","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jac\/dkg254","article-title":"Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review","volume":"51","author":"Thomas","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.017_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.01.062","article-title":"Clostridium difficile-associated diarrhea: an emerging threat to pregnant women","volume":"198.","author":"Rouphael","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"109(2\u00a0Pt2)","key":"10.1016\/j.gofs.2018.10.017_bib0230","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.AOG.0000247629.39872.b9","article-title":"Fulminant postcesarean Clostridium difficile pseudomembranous colitis","author":"Ghai","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"47","key":"10.1016\/j.gofs.2018.10.017_bib0235","first-page":"1201","article-title":"Centers for Disease Control and Prevention (CDC), Severe Clostridium difficile-associated disease in populations previously at low risk--four states","volume":"54","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.017_bib0240","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0000000000002422","article-title":"Risk factors, incidence, and morbidity associated with obstetric clostridium difficile infection","volume":"131","author":"Ruiter-Ligeti","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40121-016-0124-z","article-title":"Clostridium difficile infection in special high-risk populations","volume":"5","author":"C\u00f3zar-Llist\u00f3","year":"2016","journal-title":"Infect Dis Ther"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.017_bib0250","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl.","key":"10.1016\/j.gofs.2018.10.017_bib0255","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1093\/infdis\/135.Supplement.S104","article-title":"Diarrhea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study","volume":"135","author":"Gurwith","year":"1977","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.017_bib0260","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Community-associated Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.017_bib0265","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.02176-12","article-title":"Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection","volume":"57","author":"Brown","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","article-title":"Risk factors for Clostridium difficile infection","volume":"40","author":"Bignardi","year":"1998","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0275","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gofs.2018.10.017_bib0280","series-title":"Les antibiotiques consid\u00e9r\u00e9s comme \u00ab\u00a0critiques\u00a0\u00bb\u00a0: premi\u00e8res r\u00e9flexions sur leur caract\u00e9risation - Point d\u2019information","author":"ANSM","year":"2015"},{"issue":"Suppl. 3","key":"10.1016\/j.gofs.2018.10.017_bib0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-199100423-00005","article-title":"A review of the pharmacokinetics of cefpodoxime proxetil","volume":"42","author":"Borin","year":"1991","journal-title":"Drugs"},{"issue":"1\u20132","key":"10.1016\/j.gofs.2018.10.017_bib0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5173(03)00365-X","article-title":"Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion","volume":"263","author":"Nicolaos","year":"2003","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0295","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jac\/dkt403","article-title":"Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime","volume":"69","author":"Grohs","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0300","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10096-018-3186-x","article-title":"Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients","volume":"37","author":"de Lastours","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.017_bib0305","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jama.1966.03110170057015","article-title":"Studies on the epidemiology of adverse drug reactions. IV. The relationship of cephalothin and penicillin allergy","volume":"198","author":"Thoburn","year":"1966","journal-title":"JAMA"},{"issue":"46","key":"10.1016\/j.gofs.2018.10.017_bib0310","article-title":"Prise en charge th\u00e9rapeutique (hors antibioprophylaxie) de la rupture pr\u00e9matur\u00e9e des membranes avant terme. RPC rupture pr\u00e9matur\u00e9e des membranes avant terme","volume":"2018","author":"Madar","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0315","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9378(92)91336-9","article-title":"Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220\u00a0patients","volume":"166","author":"Mercer","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0020-7292(99)00036-3","article-title":"Prophylactic augmentin in prelabor preterm rupture of the membranes","volume":"65","author":"Magwali","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"issue":"5\u00a0Pt\u00a01","key":"10.1016\/j.gofs.2018.10.017_bib0325","first-page":"721","article-title":"Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study","volume":"73","author":"Morales","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.017_bib0330","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0002-9378(94)70220-9","article-title":"A prospective, randomized, placebo-controlled trial of penicillin in preterm premature rupture of membranes","volume":"170","author":"Ernest","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.017_bib0335","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0002-9378(93)90038-K","article-title":"Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture","volume":"169","author":"Owen","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.017_bib0340","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0002-9378(97)70398-3","article-title":"A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy","volume":"176","author":"Lovett","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0345","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1515\/JPM.2006.035","article-title":"Antibiotic therapy for preterm premature rupture of membranes - results of a multicenter study","volume":"34","author":"August Fuhr","year":"2006","journal-title":"J Perinat Med"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2007-994661","article-title":"Premature rupture of the membranes: effect of penicillin prophylaxis and long-term outcome of the children","volume":"9","author":"Kurki","year":"1992","journal-title":"Am J Perinatol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.017_bib0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/jmf.12.1.35.41","article-title":"Antibiotic administration in patients with preterm premature rupture of membranes reduces the rate of histological chorioamnionitis: a prospective, randomized, controlled study","volume":"12","author":"Ovalle","year":"2002","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.017_bib0360","first-page":"759","article-title":"Expectant management of preterm ruptured membranes: effects of antimicrobial therapy","volume":"80","author":"Christmas","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0365","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0002-9378(90)91060-P","article-title":"Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial","volume":"163","author":"Johnston","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0370","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0002-9378(88)80002-4","article-title":"Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study","volume":"159","author":"Amon","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.017_bib0375","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/0002-9378(93)90037-J","article-title":"Double-blind, placebo-controlled trial of piperacillin prophylaxis in preterm membrane rupture","volume":"169","author":"Lockwood","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.017_bib0380","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1471-0528.1997.tb14347.x","article-title":"Ampicillin-metronidazole treatment in idiopathic preterm labour: a randomised controlled multicentre trial","volume":"104","author":"Svare","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0385","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0002-9378(91)90299-7","article-title":"Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin","volume":"165","author":"McGregor","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"4\u00a0Pt 1","key":"10.1016\/j.gofs.2018.10.017_bib0390","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0002-9378(96)80049-4","article-title":"Group B Streptococcus and preterm premature rupture of membranes: a randomized, double-blind clinical trial of antepartum ampicillin","volume":"175","author":"Grable","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.017_bib0395","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.placenta.2013.01.016","article-title":"The efficacy of cefazolin plus macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and placental inflammation for women with preterm premature rupture of membranes","volume":"34","author":"Kwak","year":"2013","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.017_bib0400","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1067\/mob.2003.382","article-title":"Antibiotic therapy in preterm premature rupture of membranes: Are seven days necessary? A preliminary, randomized clinical trial","volume":"188","author":"Lewis","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0405","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0029-7844(95)00181-P","article-title":"Latency period after preterm premature rupture of membranes: a comparison of ampicillin with and without sulbactam","volume":"86","author":"Lewis","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.017_bib0410","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1067\/S0002-9378(03)00765-8","article-title":"Duration of antibiotic therapy after preterm premature rupture of fetal membranes","volume":"189","author":"Segel","year":"2003","journal-title":"Am J Obstet Gynecol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T14:25:50Z","timestamp":1551191150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918302721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2468718918302721"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.017","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choix et dur\u00e9e de l\u2019antibioprophylaxie en cas de rupture pr\u00e9matur\u00e9e des membranes avant terme. RPC rupture pr\u00e9matur\u00e9e des membranes avant terme CNGOF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}